Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPPHIRE-II: 3D Regimen + Ribavirin in Treatment-Experienced HCV GT1
NCT01715415Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of paritaprevir, ombitasvir, dasabuvir, ritonavir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Nov 2012; status: completed.
02
Drugs
paritaprevirombitasvirdasabuvirritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01715415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715415.